Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)
Authors:
- Shinichi OikawaSOShinichi Oikawa
- Mitsuhiro YokoyamaMYMitsuhiro Yokoyama
- Hideki OrigasaHOHideki Origasa
- Masunori MatsuzakiMMMasunori Matsuzaki
- Yuji MatsuzawaYMYuji Matsuzawa
- Yasushi SaitoYSYasushi Saito
- Yuichi IshikawaYIYuichi Ishikawa
- Jun SasakiJSJun Sasaki
- Hitoshi HishidaHHHitoshi Hishida
- Hiroshige ItakuraHIHiroshige Itakura
- Toru KitaTKToru Kita
- Akira KitabatakeAKAkira Kitabatake
- 1 October 2009
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 206 (2) , 535-539
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: Implication from Japan Lipid Intervention Trial (J-LIT)Atherosclerosis, 2006
- Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting GlucoseDiabetes Care, 2003
- Cardiac Benefits of Fish Consumption May Depend on the Type of Fish Meal ConsumedCirculation, 2003
- Fish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in WomenJAMA, 2002
- Large Scale Cohort Study of the Relationship Between Serum Cholesterol Concentration and Coronary Events With Low-Dose Simvastatin Therapy in Japanese Patients With HypercholesterolemiaCirculation Journal, 2002
- Large Scale Cohort Study of the Relationship Between Serum Cholesterol Concentration and Coronary Events With Low-Dose Simvastatin Therapy in Japanese Patients With Hypercholesterolemia and Coronary Heart DiseaseCirculation Journal, 2002
- Air force/texas coronary atherosclerosis prevention study (afcaps/texcaps): Additional perspectives on tolerability of long-term treatment with lovastatinThe American Journal of Cardiology, 2001
- Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol LevelsCirculation, 1998
- Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)BMJ, 1998
- Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)Diabetes Care, 1997